Tradestie Institutional Equity Comparison Engine

UTMD vs UFPT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

UTMD Overall Edge

UTMD Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Utah Medical Products Inc (UTMD) driven by superior Valuation, Growth & Margin, Momentum & Technical while UFPT counters with relative strength in Options & Structure. Fundamentally, UTMD trades at 13.0x Forward P/E with 34.3% operating margin (-12.1% YoY revenue) versus UFPT at 24.7x Forward P/E and 15.4% operating margin (+11.6% YoY). In options structure, UTMD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against UFPT sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner UTMD
UTMD 13.0x vs UFPT 24.7x Fwd P/E
Growth & Margin Winner UTMD
Op Margin 34.3% vs 15.4% ยท YoY -12.1% vs +11.6%
Momentum & Technical Winner UTMD
1Y +29.0% vs +27.4% ยท 52W Pos 80% vs 74%
Options & Structure Winner UFPT
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (3rd %ile IV)
UTMD NASDAQ
Utah Medical Products Inc
Surgical & Medical Instruments & Apparatus
$72.36
+0.54% 1D
Market Cap $204.9M
1M Return -2.89%
1Y Return +28.96%
Forward P/E 13.0x
Unified AI Score
52.9 / 100 HOLD
Tech 46.0 Fund 49.0 Flow 50.0 Mom 50.0
UFPT NASDAQ
UFP Technologies Inc
Surgical & Medical Instruments & Apparatus
$298.54
-2.14% 1D
Market Cap $2.4B
1M Return +2.36%
1Y Return +27.42%
Forward P/E 24.7x
Unified AI Score
42.6 / 100 HOLD
Tech 25.0 Fund 37.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: UTMD +28.96% UFPT +27.42% Spread: +1.54 pp (UTMD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
UTMD TTM Op. Margin: 34.3% UFPT TTM Op. Margin: 15.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UTMD vs UFPT. Trailing 12-month operating profitability (UTMD 34.3% vs UFPT 15.4%) and valuation multiples (UTMD 13.0x vs UFPT 24.7x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: UTMD (7) vs UFPT (3)
Institutional Metric UTMD UFPT Criterion Row Winner
Market Capitalization Scale $204.9M $2.4B Larger Scale UFPT
Trailing P/E Ratio Valuation 21.6x 31.2x Lower Multiple UTMD
Forward P/E Ratio Valuation 13.0x 24.7x Lower Multiple UTMD
Revenue Growth (YoY) Growth -12.1% +11.6% Higher Growth UFPT
Operating Margin (TTM) Profitability 34.3% 15.4% Higher Margin UTMD
Net Profit Margin Profitability 30.5% 11.8% Higher Margin UTMD
Return on Equity (ROE) Capital Efficiency 8.8% 17.2% Higher ROE UFPT
52-Week Range Position Momentum 80% ($54โ€“$77) 74% ($174โ€“$342) Stronger Trend UTMD
Beta / 30D Volatility Risk Regime 0.23ฮฒ ยท 33% Vol 1.64ฮฒ ยท 77% Vol Lower Realized Risk UTMD
Unified Institutional Score Composite Signal 52.9 / 100 (HOLD) 42.6 / 100 (HOLD) Higher Composite UTMD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full UTMD vs UFPT Buy Guide
UTMD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live UTMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
UFPT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live UFPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither UTMD nor UFPT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.